Alexia Bodamer, DPM
Foot & Ankle Surgery · Lousiville, KYNPI 1780212688
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,017 of the $6,178 with a category attached, or 65.0%. Stryker accounts for 71.3% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2022 at $2,682 and has fallen 58.6% since, to $1,111 in 2025.
Across 96 payments — averaging $64.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$4K
- Smith+Nephew$307
- Amgen$247
- Abbott$240
- Bioventus LLC$175
- Nevro Corp.$165
- plus $640 from 9 others
What the payments were for
- Grants$5058%
- Travel & lodging$1,65627%
- Food & beverage$4,01765%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 51 | $4,403 |
| Smith+Nephew | 26 | $307 |
| Amgen | 2 | $247 |
| Abbott | 1 | $240 |
| Bioventus LLC | 2 | $175 |
| Nevro Corp. | 2 | $165 |
| Polynovo North America LLC | 2 | $129 |
| Integra Lifesciences Corporation | 1 | $103 |
| Ossio Inc | 1 | $98 |
| Medline Industries LP | 1 | $88 |
| Arthrex | 1 | $74 |
| Alpha Orthopedic Systems | 2 | $45 |
| KCI USA, Inc. | 2 | $39 |
| Acera Surgical, Inc. | 1 | $34 |
| Boston Scientific | 1 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,178 in reported general payments places this provider in the 65th percentile of 141 foot & ankle surgery providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole | 21 | $453 |
| Methylprednisolone | 46 | $214 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 15 | $199 |
| Meloxicam | 106 | $158 |
| Terbinafine Hcl | 13 | $53 |
| Cephalexin | 12 | $41 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Lousiville
- William Adams IiPaducah$485K
- Sofie PinneyCynthiana$130K
- Carl KihmLouisville$89K
- Bradford FineLexington$82K
- Nicholas LacoLouisville$60K
- Jay LechnerLouisville$29K
- Russell BakerCarrollton$27K
- William McGloneLouisville$26K
- Timothy FordLouisville$26K
- Garrett WiremanLouisville$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.